TGF-β1/Smads play an important role in the progression of AKI to CKD, where it has been shown that inhibiting TGF-β1 signaling worsens acute injury but its inhibition in the chronic phase is protective against fibrosis [106,107]. Here, TGFB1 is linked to chronic kidney disease.